{"id":"asa-withdrawn-group","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is not a drug itself, but rather a control or comparator group in clinical trials examining the effects of aspirin withdrawal. Studies of ASA-withdrawn groups help evaluate whether discontinuation of antiplatelet therapy leads to increased thrombotic events, inflammation, or other adverse cardiovascular outcomes compared to continued aspirin use or placebo.","oneSentence":"ASA-withdrawn group refers to a cohort of patients who discontinued aspirin therapy, typically studied to assess rebound thrombotic or cardiovascular effects.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:02:40.609Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Aspirin withdrawal effects in cardiovascular disease (study cohort, not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT05225961","phase":"PHASE4","title":"ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2022-05-01","conditions":"Acute Ischemic Stroke","enrollment":240},{"nctId":"NCT06728514","phase":"PHASE2, PHASE3","title":"Comparative Study of USG Guided ESPB vs USG Guided PVB For Post-op Analgesia In Patient's After Open Renal Surgeries","status":"COMPLETED","sponsor":"Sahiwal medical college sahiwal","startDate":"2024-01-11","conditions":"Post Operative Analgesia, Hemodynamic (MAP) Stability, Renal Surgeries","enrollment":72},{"nctId":"NCT03741179","phase":"PHASE3","title":"Detection of False Positives From First-trimester Preeclampsia Screening (StopPRE) at the Second-trimester of Pregnancy","status":"COMPLETED","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2019-08-20","conditions":"Pre-Eclampsia","enrollment":974},{"nctId":"NCT03757156","phase":"NA","title":"Aspirin Withdrawal and Clinical Outcome in Patients With Moderate to High Cardiovascular Risk But Without Cardiovascular Disease","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-03","conditions":"Healthy Participants With Moderate and High Cardiovascular Risk","enrollment":4118},{"nctId":"NCT00857155","phase":"NA","title":"Time Based Strategy to Reduce Clopidogrel Associated Bleeding Related to Coronary Artery Bypass Graft (CABG)","status":"UNKNOWN","sponsor":"LifeBridge Health","startDate":"2009-01","conditions":"Coronary Artery Disease","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3715081,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["sFlt y PlGF ratio less than 38."],"phase":"phase_3","status":"active","brandName":"ASA-withdrawn group","genericName":"ASA-withdrawn group","companyName":"Hospital Universitari Vall d'Hebron Research Institute","companyId":"hospital-universitari-vall-d-hebron-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ASA-withdrawn group refers to a cohort of patients who discontinued aspirin therapy, typically studied to assess rebound thrombotic or cardiovascular effects. Used for Aspirin withdrawal effects in cardiovascular disease (study cohort, not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}